Fundz

Evogene Announces $10 Million Equity Led Investment by ARK Investment Management, LLC

PUBLIC · EVGNSep 01, 2020

Amount Raised

$10 Million

Round Type

Venture

RehovotBiotechnologyArtificial Intelligence

Description

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, today announced that it has entered into a definitive agreement with ARK Investment Management, LLC (ARK Invest) and Alpha Capital Anstalt in connection with a registered direct offering of ordinary shares at a price per share of $1.70, for an aggregate cash consideration of $10 million. Of the aggregate investment amount, ARK Invest, a leading technology investment firm, specializing in thematic investing in disruptive innovation, will invest $7 million and Alpha Capital Anstalt will invest $3 million.

Quick answer

Evogene raised $10 Million in a funding round, dated September 1, 2020. Evogene is based in Rehovot, Center District, Israel.

How much did Evogene raise?
Evogene raised $10 Million in a funding round on September 1, 2020.
What does Evogene do?
Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries.
Where is Evogene based and how big is it?
Evogene is based in Rehovot, Center District, Israel. Fundz records about 108 employees.
Who are the decision-makers at Evogene?
Fundz holds 4 contacts at Evogene, including the Executive Vice President Technology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Artificial Intelligence around the same time

Companies in the same sectors as Evogene that raised within 45 days of this round, from Fundz verified event records.

  • SRX Global Inc. raised $19M on October 15, 2020.
  • Ovation raised $21M on October 9, 2020.
  • Pictor Labs raised $617K (Seed) on October 7, 2020.
  • Recursion Pharmaceuticals raised $236M on September 15, 2020.
  • Opentrons Labworks raised $21M on August 25, 2020.
  • Mantra Bio raised $30M on August 12, 2020.

Who to call at Evogene, and when

A new round usually means Evogene is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Evogene raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evogene, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evogene. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Evogene

Location

Rehovot, Center District, Israel

About

Evogene Ltd. (Nasdaq/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. We call this approach "Real-World Innovation".

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Evogene raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsMark K., Executive Vice President Technology hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Evogene's next move

See what Strategic adds

Evogene raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.